Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
Hematol., Transfus. Cell Ther. (Impr.)
; 42(4): 300-308, Oct.-Dec. 2020. tab
Article
de En
| LILACS
| ID: biblio-1142978
Bibliothèque responsable:
BR408.1
Localisation: BR408.1
ABSTRACT
ABSTRACT Hemostatic abnormalities and thrombotic risk associated with coronavirus disease 2019 (COVID-19) are among the most discussed topics in the management of this disease. The aim of this position paper is to provide the opinion of Brazilian experts on the thromboprophylaxis and management of thrombotic events in patients with suspected COVID-19, in the sphere of healthcare in Brazil. To do so, the Brazilian Society of Thrombosis and Hemostasis (BSTH) and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) have constituted a panel of experts to carefully review and discuss the available evidence about this topic. The data discussed in this document was reviewed by May 9, 2020. Recommendations and suggestions reflect the opinion of the panel and should be reviewed periodically as new evidence emerges.
Mots clés
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Troubles de l'hémostase et de la coagulation
/
Thromboembolisme veineux
/
COVID-19
Type d'étude:
Diagnostic_studies
/
Guideline
/
Risk_factors_studies
Pays comme sujet:
America do sul
/
Brasil
langue:
En
Texte intégral:
Hematol., Transfus. Cell Ther. (Impr.)
Thème du journal:
Hematologia
/
TransfusÆo de Sangue
Année:
2020
Type:
Article